Nasal Corticosteroids Market Report 2026

Nasal Corticosteroids Market Overview

• Nasal Corticosteroids market size has reached to $6.7 billion in 2025 • Expected to grow to $9.87 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Increasing Respiratory Disease Cases Fueling The Growth Of The Market Due To Rising Air Pollution And Sedentary Lifestyles • Market Trend: Optinose FDA Approval Utilizing Exhalation Delivery System To Treat Chronic Rhinosinusitis Without Nasal Polyps • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nasal Corticosteroids Market?

Nasal corticosteroids refer to corticosteroid medications that are administered via the nose (typically as a nasal spray) to reduce inflammation in the nasal passages. They are commonly used to treat allergic rhinitis, nasal polyps, and chronic sinusitis, helping to relieve symptoms such as nasal congestion, sneezing, and a runny nose by reducing swelling and inflammation of the nasal mucosa. The main product types of nasal corticosteroids are aqueous nasal sprays and non-aqueous nasal sprays. Aqueous nasal sprays refer to water-based nasal spray formulations used to deliver medications directly into the nasal passages. The multiple drug types involved are fluticasone propionate, budesonide, beclomethasone dipropionate, mometasone furoate, triamcinolone acetonide, ciclesonide, and others that are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others and are used for various applications such as allergic rhinitis, nasal polyps, sinusitis, and others and cater to several end users such as hospitals, clinics, homecare settings and others.

What Is The Nasal Corticosteroids Market Growth Forecast?

The nasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.87 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of advanced non-aqueous and oil-based nasal sprays, increasing patient preference for self-administration, rising prevalence of chronic sinusitis and nasal polyps, expansion of e-pharmacy and homecare distribution, innovation in targeted corticosteroid formulations. Major trends in the forecast period include rising prevalence of allergic rhinitis and chronic sinusitis, increasing adoption of aqueous and non-aqueous nasal sprays, growth in homecare and self-administration treatments, expansion of online and retail pharmacy channels, focus on formulation innovation and patient compliance.

Global Nasal Corticosteroids Market Segmentation

1) By Product Type: Aqueous Nasal Sprays, Non-Aqueous Nasal Sprays 2) By Drug Type: Fluticasone Propionate, Budesonide, Beclomethasone Dipropionate, Mometasone Furoate, Triamcinolone Acetonide, Ciclesonide, Other Drug Types 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels 4) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications 5) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Aqueous Nasal Sprays: Metered-Dose Aqueous Nasal Sprays, Pump-Action Aqueous Nasal Sprays 2) By Non-Aqueous Nasal Sprays: Hydroalcoholic Nasal Sprays

What Is The Driver Of The Nasal Corticosteroids Market?

The increasing prevalence of respiratory diseases is expected to propel the growth of the nasal corticosteroids market going forward. Respiratory diseases refer to health problems that affect the lungs and make it hard to breathe, often causing coughing or shortness of breath. The increasing prevalence of respiratory diseases is due to rising air pollution and busy modern lifestyles characterized by exposure to harmful pollutants, smoking, and limited physical activity, which negatively impact lung health and increase the risk of breathing problems. Nasal corticosteroids help respiratory diseases by reducing swelling in the nasal passages, easing breathing, relieving symptoms such as congestion and sneezing, and improving overall airflow for better respiratory comfort. For instance, in June 2025, according to the Office for Health Improvement and Disparities, a UK-based government department, between the financial years ending 2023 and 2024, the rate of emergency admissions for respiratory diseases in England rose by 7%, with specific increases of 9% for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the increasing prevalence of respiratory diseases is driving the growth of the nasal corticosteroids industry.

Key Players In The Global Nasal Corticosteroids Market

Major companies operating in the nasal corticosteroids market are Pfizer Inc., Merck & Co Inc., Bayer AG, Sanofi S.A., GSK plc , Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Limited, Glenmark Pharmaceuticals Ltd, Pharmascience Inc., Mylan N.V.

Global Nasal Corticosteroids Market Trends and Insights

Major companies operating in the nasal corticosteroids market are focusing on regulatory approval of innovative medications, such as exhalation delivery systems (EDS)-based nasal spray, to enhance drug delivery efficiency, improve treatment outcomes, and increase patient compliance. Exhalation delivery systems based on nasal spray refer to traditional nasal sprays that use the patient’s exhaled breath to close the soft palate and deliver medication high and deep into the nasal passages, improving drug deposition at inflamed sites. For instance, in May 2024, Optinose, Inc., a US-based pharmaceutical company, received FDA approval for XHANCE (fluticasone propionate) nasal spray as the first and only medication indicated for the treatment of adults with chronic rhinosinusitis without nasal polyps (CRSsNP). XHANCE utilizes a unique exhalation delivery system (EDS) technology to deliver corticosteroids deep into the nasal passages using a gentle exhalation, providing targeted anti-inflammatory action for chronic rhinosinusitis. This technology offers an alternative to traditional nasal sprays, which often have limited reach within the nasal cavity, by enabling effective medication delivery to hard-to-reach inflamed areas. XHANCE helps relieve nasal congestion and facial pressure associated with chronic rhinosinusitis without nasal polyps. It supports patients requiring long-term management of the condition while avoiding invasive procedures or the systemic side effects commonly associated with oral corticosteroids.

What Are Latest Mergers And Acquisitions In The Nasal Corticosteroids Market?

In March 2025, Paratek Pharmaceuticals Inc., a US-based biopharmaceutical company, acquired OptiNose Inc. for an undisclosed amount. Through this acquisition, Paratek Pharmaceuticals Inc. aims to strengthen its position in the respiratory and ear, nose, and throat (ENT) therapeutics market and expand its portfolio with innovative nasal drug delivery solutions such as XHANCE of OptiNose. OptiNose Inc. is a US-based pharmaceutical company that specializes in nasal corticosteroids.

Regional Insights

North America was the largest region in the nasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nasal Corticosteroids Market?

The nasal corticosteroids market includes sales of sprays, inhalers, drops, gels, and ointments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nasal Corticosteroids Market Report 2026?

The nasal corticosteroids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nasal corticosteroids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.